--- title: "Eyepoint Pharmaceuticals 宣布启动 Duravy 用于治疗糖尿病黄斑水肿的三期临床项目" description: "10 月 14 日（路透社）- Eyepoint Pharmaceuticals Inc：* Eyepoint Pharmaceuticals Inc - 宣布启动针对糖尿病性黄斑水肿的 DURAVY 的第三阶段项目 来源文本：进一步的公司报道：" type: "news" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/261129466.md" published_at: "2025-10-14T20:21:40.000Z" --- # Eyepoint Pharmaceuticals 宣布启动 Duravy 用于治疗糖尿病黄斑水肿的三期临床项目 > 10 月 14 日（路透社）- Eyepoint Pharmaceuticals Inc：* Eyepoint Pharmaceuticals Inc - 宣布启动针对糖尿病性黄斑水肿的 DURAVY 的第三阶段项目 来源文本：进一步的公司报道： 10 月 14 日（路透社）- Eyepoint Pharmaceuticals Inc (EYPT.O)：\* Eyepoint Pharmaceuticals Inc - 宣布启动针对糖尿病性黄斑水肿的 Duravy 的第三阶段项目 来源文本：进一步公司报道：（EYPT.O） ### Related Stocks - [EYPT.US - EyePoint](https://longbridge.com/zh-CN/quote/EYPT.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | EyePoint Pharmaceuticals Teases Mid-2026 DURAVYU Wet AMD Data, Starts Phase III DME Program | EyePoint Pharmaceuticals (NASDAQ:EYPT) presented at the Guggenheim Emerging Biotech Summit 2026, discussing its lead ret | [Link](https://longbridge.com/zh-CN/news/275950536.md) | | EyePoint Inc. to Present at Guggenheim Emerging Outlook Biotech Summit | EyePoint Inc. will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12 | [Link](https://longbridge.com/zh-CN/news/274967127.md) | | EyePoint Inc. Chief Medical Officer Ramiro Ribeiro Reports Disposal of Common Shares | Ramiro Ribeiro, Chief Medical Officer of EyePoint Inc., has reported the disposal of common shares of the company. The f | [Link](https://longbridge.com/zh-CN/news/271837277.md) | | EyePoint Pharmaceuticals (EYPT) Valuation Check After DURAVYU Phase 3 And NDA Progress | EyePoint Pharmaceuticals (EYPT) is under scrutiny following updates on DURAVYU's Phase 3 trials and potential NDA filing | [Link](https://longbridge.com/zh-CN/news/272184213.md) | | EyePoint Inc. to Present at J.P. Morgan Healthcare Conference | EyePoint Inc. will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2026, at | [Link](https://longbridge.com/zh-CN/news/271784400.md) | --- > **免责声明**：本文内容仅供参考，不构成任何投资建议。